<DOC>
	<DOC>NCT01612741</DOC>
	<brief_summary>In this prospective, non interventional, observational Post Marketing Survelliance study data are obtained on the efficacy, safety and tolerability of Glucobay treatment on top of metformin under daily life treatment conditions.Specifically investigated is the influence of Glucobay on Post Prandial Blood Glucose and HbA1c as well as on pateint's weight when added to an already existing metformin therapy.The study is planned to carried out in 25000 - 30000 patients from 200 trial sites in India.The PMS study will be performed with commercially available medication prescribed within regular practice of the physician. No other examination will be performed than would be done without Post Marketing Survelliance study.</brief_summary>
	<brief_title>Diabetes Treatment With Glucobay in Combination With Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>All patient with type 2 diabetes with one of the following treatment ongoing : 1) Metformin 2) Metformin + OHA. In such patients, if investigator feels that addition of acarbose would be benficial for the patients According to local product information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Diabetes Mellitus, Type-2</keyword>
	<keyword>Acarbose</keyword>
	<keyword>Drug Therapy</keyword>
	<keyword>Combination</keyword>
</DOC>